VLS Valneva SE

VALNEVA - Declaration of shares and voting rights: Interim status at October 4, 2022 (and information at September 30, 2022)

VALNEVA - Declaration of shares and voting rights: Interim status at October 4, 2022 (and information at September 30, 2022)

VALNEVA

Declaration of shares and voting rights

Interim status at October 4, 2022 (and information at September 30, 2022)

__________________________________________________________________________________________

  

Company name: VALNEVA

Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)

Regulated market of Euronext Paris - Compartment A

Declaration date: October 7, 2022

  

Interim status at October 4, 2022

Number of shares

composing the share capital of Valneva
Total number of voting rights including suspended voting rights*Description of the changeDate on which this change was recognizedTotal number of voting rights excluding suspended voting rights**
 



138,351,857



 



    including:
  • 138,331,343 ordinary shares with a par value of €0.15 each; and
  • 20,514 preferred shares convertible into ordinary shares, with a par value of €0.15 each
160,905,006Capital increase without preferential subscription rights (21,000,000 new ordinary shares issued)



 
October 4, 2022i160,780,684

i Management Board decisions of September 29, 2022. Clearance and settlement on October 4, 2022.

Information at September 30, 2022

Number of shares

composing the share capital of Valneva
Total number of voting rights including suspended voting rights*Description of the changeDate on which this change was recognizedTotal number of voting rights excluding suspended voting rights**
 



117,351,857



 



    including:
  • 117,331,343 ordinary shares with a par value of €0.15 each; and
  • 20,514 preferred shares convertible into ordinary shares, with a par value of €0.15 each
139,905,006Sale of 1,101 shares with double voting rights



 



Double voting rights granted on 65 ordinary shares
September 7 & 12, 2022



 



September 18, 2022
139,780,684

 ___________________________

* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

** Net (or exercisable at a General Meeting) voting rights.

Attachment



EN
07/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Valneva SE

Martial Descoutures
  • Martial Descoutures
Damien Choplain ... (+2)
  • Damien Choplain
  • Oscar Haffen Lamm

Valneva : Strong H1 - Key Lyme vaccine catalyst ahead in Q4

Valneva delivered a solid H1 and reaffirmed its 2025 guidance. The company’s cash position, standing at €161m, is sufficient to fund operations through 2027e, providing solid financial visibility. Looking ahead, the next key catalyst is the Phase III data readout for VLA15, Valneva’s Lyme disease v

Martial Descoutures
  • Martial Descoutures

ResearchPool Subscriptions

Get the most out of your insights

Get in touch